These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 12135803)
1. Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing. Benn PA Clin Chim Acta; 2002 Sep; 323(1-2):1-16. PubMed ID: 12135803 [TBL] [Abstract][Full Text] [Related]
5. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age. Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608 [TBL] [Abstract][Full Text] [Related]
6. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343 [TBL] [Abstract][Full Text] [Related]
7. Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions. Benn PA Clin Chim Acta; 2002 Oct; 324(1-2):1-11. PubMed ID: 12204419 [TBL] [Abstract][Full Text] [Related]
13. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related]
14. Prenatal screening for Down's syndrome with use of maternal serum markers. Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344 [TBL] [Abstract][Full Text] [Related]
15. Practical strategies in contingent sequential screening for Down syndrome. Benn P; Wright D; Cuckle H Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988 [TBL] [Abstract][Full Text] [Related]
16. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701 [TBL] [Abstract][Full Text] [Related]
17. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. Wald NJ; Watt HC; Hackshaw AK N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601 [TBL] [Abstract][Full Text] [Related]
18. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment. Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355 [TBL] [Abstract][Full Text] [Related]
20. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Biggio JR; Morris TC; Owen J; Stringer JS Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]